Ainos, Inc. filed a current report on November 20, 2026, disclosing that it received a Nasdaq deficiency letter on November 18, 2026, notifying the company that its stockholders' equity fell below the minimum required for continued listing on The Nasdaq Capital Market.
Key Highlights
- Deficiency identified: Ainos reported stockholders' equity of $1,721,037 as of September 30, 2026, below the $2,500,000 minimum required by Nasdaq Listing Rule 5550(b)(1).
- No immediate trading impact: According to the filing, the Nasdaq letter "has no immediate effect on the listing or trading of the Company's common stock on The Nasdaq Capital Market under the symbol 'AIMD.'"
- Response deadline: The company has until January 4, 2027, 45 calendar days from the date of the letter, to submit a compliance plan to Nasdaq.
- Potential extension: If Nasdaq accepts the plan, the company may receive an extension of up to 180 calendar days from the date of the letter to demonstrate compliance.
- Remedies under consideration: Management disclosed it is evaluating potential conversion of outstanding debt into equity and other capital-raising alternatives to strengthen stockholders' equity.
- Alternative standards not met: As of the date of the letter, the filing states the company also did not meet either of the alternative continued listing standards based on market value of listed securities or net income from continuing operations.
Ainos Discloses Stockholders' Equity Shortfall and Compliance Timeline
Ainos, Inc., a Texas-incorporated company listed on NASDAQ:AIMD and headquartered in Houston, Texas, disclosed that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC on November 18, 2026. The letter notified the company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain stockholders' equity of at least $2,500,000 for continued listing. The company reported stockholders' equity of $1,721,037 as of September 30, 2026, in its quarterly report for the period ended that date.
According to the filing, the company did not qualify under either of the two alternative continued listing standards at the time of the letter. Those alternatives are based on the market value of listed securities and net income from continuing operations, respectively. The filing notes that the deficiency letter carries no immediate consequence for the trading status of the company's common stock or its warrants, which trade on Nasdaq under the symbol "AIMDW."
The company disclosed that it is preparing a plan to regain compliance and intends to submit it to Nasdaq by January 4, 2027. Among the measures under evaluation, management cited the potential conversion of outstanding debt into equity and other capital-raising alternatives. The filing cautions, in the company's own language, that "there can be no assurance that Nasdaq will accept the plan, that the Company will complete any transaction under consideration, or that the Company will regain compliance with the Minimum Stockholders' Equity Requirement or maintain compliance with other applicable Nasdaq continued listing requirements." Statements regarding the compliance plan and potential capital transactions are characterized in the filing as forward-looking statements subject to risks and uncertainties.
What Was Disclosed
Ainos, Inc. reported receiving a Nasdaq deficiency notice on November 18, 2026, citing stockholders' equity of $1,721,037 against a $2,500,000 minimum threshold. The company has until January 4, 2027, to submit a remediation plan and may receive up to 180 additional calendar days if the plan is accepted.



Please wait processing your request...